Acoplamiento molecular de derivados de la 6-(piridin)-7H-indeno[2,1-c]quinolina como inhibidores de la Topoisomerasa 1 y PARP 1

Autores/as

  • Cristian C Bernal Instituto Universitario de la Paz, Barrancabermeja, Santander, Colombia

DOI:

https://doi.org/10.24054/bistua.v20i2.1434

Palabras clave:

Acoplamiento molecular, Topoisomerasa 1, PARP 1, Interacción Ligando-Proteína, Indeno[2,1-c]quinolinas

Resumen

Una variedad de compuestos derivados de la 7H-indeno[2,1-c]quinolina han sido reportados ya que poseen propiedades anticáncer significativas. Sin embargo, los modos de acción aún no están claramente definidos. Se seleccionaron treinta derivados 6-(pyridin)-7H-indeno[2,1-c]quinolínicos los cuales exhiben actividad anticáncer y fueron sometidos a cálculos de acoplamiento molecular usando AutodockVina. Para investigar preliminarmente las dianas moleculares potenciales y confirmar la prueba de actividad experimental para estos compuestos anticancerígenos, el acoplamiento se realizó utilizando dos enzimas involucradas en el ciclo celular y en la replicación del ADN, e.g topoisomerasa 1 y PARP 1 (Poli [ADP-ribosa] polimerasa 1). Los resultados de acoplamiento revelaron que la 6-(piridin-4-il)-7H-indeno[2,1-c]quinolina-2-carboxamida 1j exhibió una mejor interacción de unión que el conocido inhibidor (D7N) co-cristalizado dentro de la (Poli [ADP-ribosa] polimerasa 1). Por otro lado, la 2-fluoro-6-(piridin-2-il)-7H-indeno[2,1-c]quinolina 3e se unió mejor a la ADN topoisomerasa 1. Los resultados obtenidos son útiles para comprender las características estructurales necesarias para mejorar las actividades inhibidoras.

357 401

Descargas

Los datos de descarga aún no están disponibles.

Referencias

Li, J., Fu, A., & Zhang, L. (2019). An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking. Interdisciplinary Sciences – Computational Life Sciences, 11(2), 320–328. https://doi.org/10.1007/s12539-019-00327-w

Fu, Y., Zhao, J., & Chen, Z. (2018). Insights into the Molecular Mechanisms of Protein-Ligand Interactions by Molecular Docking and Molecular Dynamics Simulation: A Case of Oligopeptide Binding Protein. Computational and Mathematical Methods in Medicine, 2018. https://doi.org/10.1155/2018/3502514

Wu, Q., Peng, Z., Zhang, Y., & Yang, J. (2018). COACH-D: Improved protein-ligand binding sites prediction with refined ligand-binding poses through molecular docking. Nucleic Acids Research, 46(W1), W438–W442. https://doi.org/10.1093/nar/gky439

Ammar, Y. A., Sh El-Sharief, A. M., Belal, A., Abbas, S. Y., Mohamed, Y. A., Mehany, A. B. M., & Ragab, A. (2018). Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity. European Journal of Medicinal Chemistry, 156, 918–932. https://doi.org/10.1016/j.ejmech.2018.06.061

AboulWafa, O. M., Daabees, H. M. G., & Badawi, W. A. (2020). 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study. Bioorganic Chemistry, 99(March), 103798. https://doi.org/10.1016/j.bioorg.2020.103798

Gurung, A. B., Ali, M. A., Bhattacharjee, A., Abul Farah, M., Al-Hemaid, F., Abou-Tarboush, F. M., Al-Anazi, K. M., Al-Anazi, F. S. M., & Lee, J. (2016). Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication. Genetics and Molecular Research, 15(2), 1–8. https://doi.org/10.4238/gmr.15027829

Fielden, J., Wiseman, K., Torrecilla, I., Li, S., Hume, S., Chiang, S. C., Ruggiano, A., Narayan Singh, A., Freire, R., Hassanieh, S., Domingo, E., Vendrell, I., Fischer, R., Kessler, B. M., Maughan, T. S., El-Khamisy, S. F., & Ramadan, K. (2020). TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts. Nature Communications, 11(1), 1–16. https://doi.org/10.1038/s41467-020-15000-w

Zhao, B., Liu, P., Fukumoto, T., Nacarelli, T., Fatkhutdinov, N., Wu, S., Lin, J., Aird, K. M., Tang, H. Y., Liu, Q., Speicher, D. W., & Zhang, R. (2020). Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence. Nature Communications, 11(1). https://doi.org/10.1038/s41467-020-14652-y

Takahashi, D. T., Gadelle, D., Agama, K., Kiselev, E., Zhang, H., Yab, E., Petrella, S., Forterre, P., Pommier, Y., & Mayer, C. (2022). Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states. Nature Communications, 13(1). https://doi.org/10.1038/s41467-021-27686-7

Promonet, A., Padioleau, I., Liu, Y., Sanz, L., Biernacka, A., Schmitz, A. L., Skrzypczak, M., Sarrazin, A., Mettling, C., Rowicka, M., Ginalski, K., Chedin, F., Chen, C. L., Lin, Y. L., & Pasero, P. (2020). Topoisomerase 1 prevents replication stress at R-loop-enriched transcription termination sites. Nature Communications, 11(1), 1–12. https://doi.org/10.1038/s41467-020-17858-2

Saha, L. K., Wakasugi, M., Akter, S., Prasad, R., Wilson, S. H., Shimizu, N., Sasanuma, H., Huang, S. Y. N., Agama, K., Pommier, Y., Matsunaga, T., Hirota, K., Iwai, S., Nakazawa, Y., Ogi, T., & Takeda, S. (2020). Topoisomerase I-driven repair of UV-induced damage in NER-deficient cells. Proceedings of the National Academy of Sciences of the United States of America, 117(25), 14412–14420. https://doi.org/10.1073/pnas.1920165117

Li, F., Li, S., Guo, X., Dong, Y., Yao, C., Liu, Y., Song, Y., Tan, X., Gao, L., & Yang, D. (2020). Chiral Carbon Dots Mimicking Topoisomerase I To Mediate the Topological Rearrangement of Supercoiled DNA Enantioselectively. Angewandte Chemie -International Edition, 59(27), 11087–11092. https://doi.org/10.1002/anie.202002904

Nilov, D., Maluchenko, N., Kurgina, T., Pushkarev, S., Lys, A., Kutuzov, M., Gerasimova, N., Feofanov, A., Švedas, V., Lavrik, O., & Studitsky, V. M. (2020). Molecular mechanisms of PARP-1 inhibitor 7-methylguanine. International Journal of Molecular Sciences, 21(6), 1–11. https://doi.org/10.3390/ijms21062159

Zandarashvili, L., Langelier, M. F., Velagapudi, U. K., Hancock, M. A., Steffen, J. D., Billur, R., Hannan, Z. M., Wicks, A. J., Krastev, D. B., Pettitt, S. J., Lord, C. J., Talele, T. T., Pascal, J. M., & Black, B. E. (2020). Structural basis for allosteric PARP-1 retention on DNA breaks. Science, 368(6486). https://doi.org/10.1126/science.aax6367

Ramadan, S. K., Elrazaz, E. Z., Abouzid, K. A. M., & El-Naggar, A. M. (2020). Design, synthesis and: In silico studies of new quinazolin one derivatives as antitumor PARP-1 inhibitors. RSC Advances, 10(49), 29475–29492. https://doi.org/10.1039/d0ra05943a

Martino, E.; Della, S.; Terribile, E.; Benetti, E.; Sakaj, M.; Centamore, A.; Sala, A.; Collina, S. Bioorganic & Medicinal Chemistry Letters The Long Story of Camptothecin : From Traditional Medicine to Drugs. Bioorg. Med. Chem. Lett.2017.1,1-17. https://doi.org/10.1016/j.bmcl.2016.12.085

Huang, Q.; Wang, L.; Lu, W. European Journal of Medicinal Chemistry Evolution in Medicinal Chemistry of E-Ring-Modified Camptothecin Analogs as Anticancer Agents. Eur. J. Med. Chem.2013. 63, 746–757. https://doi.org/10.1016/j.ejmech.2013.01.058

Munagala, S.; Sirasani, G.; Kokkonda, P.; Phadke, M.; Krynetskaia, N.; Lu, P.; Sharom, F. J.; Chaudhury, S.; Abdulhameed, M. D. M.; Tawa, G.; et al. Synthesis and Evaluation of Strychnos Alkaloids as MDR Reversal Agents for Cancer Cell Eradication. Bioorganic Med. Chem.2014. 22, 1148–1155. https://doi.org/10.1016/j.bmc.2013.12.022

Tavares, T. S., Hofman, J., Lekešová, A., Želazková, J., & Wsól, V. (2020). Olaparib synergizes the anticancer activity of daunorubicin via interaction with akr1c3. Cancers, 12(11), 1–16. https://doi.org/10.3390/cancers12113127

Sahin, K., & Durdagi, S. (2021). Identifying new piperazine-based PARP1 inhibitors using text mining and integrated molecular modeling approaches. Journal of Biomolecular Structure and Dynamics, 39(2), 681–690. https://doi.org/10.1080/07391102.2020.1715262

Wang, B. L., Pan, D. Q., Kou, S. B., Lin, Z. Y., & Shi, J. H. (2020). Exploring the binding interaction between bovine serum albumin and perindopril as well as influence of metal ions using multi-spectroscopic, molecular docking and DFT calculation. Chemical Physics, 530(May 2019), 110641. https://doi.org/10.1016/j.chemphys.2019.110641

Becke A.D. Density-functional thermochemistry. IV. A new dynamical correlation functional and implications for exact-exchange mixing. J. Chem. Phys.1996. 104, 1040 -1046. https://doi.org/10.1063/1.470829

Mullay J. A simple method for calculating atomic charge in molecules. J. Am. Chem. Soc.1986. 108, 1770 -1775. https://doi.org/10.1021/ja00268a010

Morris, G.; Huey, R.; Lindstrom, W.; Sanner, M.; Belew, R.; Goodsell, D.; Olso, A. AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. J Comput Chem. 2009 Dec; 30(16): 2785–2791. https://doi.org/10.1002/jcc.21256

Descargas

Publicado

2022-10-27 — Actualizado el 2022-10-27

Cómo citar

Bernal, C. C. (2022). Acoplamiento molecular de derivados de la 6-(piridin)-7H-indeno[2,1-c]quinolina como inhibidores de la Topoisomerasa 1 y PARP 1 . BISTUA Revista De La Facultad De Ciencias Básicas, 20(2), 14-20. https://doi.org/10.24054/bistua.v20i2.1434

Artículos similares

31-40 de 66

También puede Iniciar una búsqueda de similitud avanzada para este artículo.